Chan Basho

Chan Basho is Chief Strategy Officer and Interim Chief Financial Officer at ApolloMed, where he is responsible for leading the development and execution of ApolloMed’s finance, strategy and operations along with improving operating discipline to ensure the Company’s ability to scale successfully.

Mr. Basho possesses 15 years of experience in strategy, finance, and operations at reputable healthcare companies, most recently having served as Vice President of Strategy and Corporate Development at Alignment Healthcare since 2018. From 2017 to 2018, Mr. Basho served as Chief Financial Officer at Alsana, a private equity-backed behavioral health company. From 2014 to 2017, Mr. Basho served in different positions at HealthCare Partners, a DaVita Medical Group company, including as Vice President of Strategy and Corporate Development leading strategy and development for the California market. From 2007 to 2014, Mr. Basho served in different capacities related to strategy and finance at DaVita Kidney Care, including as Director of Corporate Finance.

Mr. Basho received a bachelor’s degree in Bioengineering from the University of California, Berkeley, and an MBA from the Wharton School at the University of Pennsylvania.